ANI Pharmaceuticals Inc (ANIP)
65.38
+0.78
(+1.22%)
USD |
NASDAQ |
Apr 19, 15:22
ANI Pharmaceuticals Shareholders Equity (Quarterly): 457.60M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 457.60M |
September 30, 2023 | 454.71M |
June 30, 2023 | 434.47M |
March 31, 2023 | 339.48M |
December 31, 2022 | 338.54M |
September 30, 2022 | 336.68M |
June 30, 2022 | 336.96M |
March 31, 2022 | 346.09M |
December 31, 2021 | 358.74M |
September 30, 2021 | 191.40M |
June 30, 2021 | 191.92M |
March 31, 2021 | 203.71M |
December 31, 2020 | 195.70M |
September 30, 2020 | 195.10M |
June 30, 2020 | 191.34M |
March 31, 2020 | 201.17M |
December 31, 2019 | 212.79M |
September 30, 2019 | 213.13M |
June 30, 2019 | 207.66M |
March 31, 2019 | 199.71M |
December 31, 2018 | 197.26M |
September 30, 2018 | 192.46M |
June 30, 2018 | 185.11M |
March 31, 2018 | 179.64M |
December 31, 2017 | 174.76M |
Date | Value |
---|---|
September 30, 2017 | 182.80M |
June 30, 2017 | 176.55M |
March 31, 2017 | 172.21M |
December 31, 2016 | 169.65M |
September 30, 2016 | 168.83M |
June 30, 2016 | 163.78M |
March 31, 2016 | 160.18M |
December 31, 2015 | 160.08M |
September 30, 2015 | 155.89M |
June 30, 2015 | 149.50M |
March 31, 2015 | 144.74M |
December 31, 2014 | 139.78M |
September 30, 2014 | 99.49M |
June 30, 2014 | 91.60M |
March 31, 2014 | 92.09M |
December 31, 2013 | 40.96M |
September 30, 2013 | 36.69M |
June 30, 2013 | 35.49M |
March 31, 2013 | 26.03M |
December 31, 2012 | 28.18M |
September 30, 2012 | 32.29M |
June 30, 2012 | 30.92M |
March 31, 2012 | 38.00M |
December 31, 2011 | 37.82M |
September 30, 2011 | 44.15M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
191.34M
Minimum
Jun 2020
457.60M
Maximum
Dec 2023
284.59M
Average
213.13M
Median
Sep 2019
Shareholders Equity (Quarterly) Benchmarks
ADMA Biologics Inc | 135.21M |
Ligand Pharmaceuticals Inc | 700.91M |
Dentsply Sirona Inc | 3.293B |
Allogene Therapeutics Inc | 512.23M |
Vanda Pharmaceuticals Inc | 544.91M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 904.42M |
Total Liabilities (Quarterly) | 446.82M |
Debt to Equity Ratio | 0.6243 |
Current Ratio | 3.573 |
Net Debt Paydown Yield | 0.02% |